phosphatidylcholines has been researched along with salinomycin in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (salinomycin) | Trials (salinomycin) | Recent Studies (post-2010) (salinomycin) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 672 | 30 | 409 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | salinomycin (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riddell, FG; Tompsett, SJ | 1 |
| Narayanaswamy, R; Torchilin, VP | 1 |
2 other study(ies) available for phosphatidylcholines and salinomycin
| Article | Year |
|---|---|
The transport of Na+ and K+ ions through phospholipid bilayers mediated by the antibiotics salinomycin and narasin studied by 23Na- and 39K-NMR spectroscopy.
Topics: Anti-Bacterial Agents; Ionophores; Kinetics; Lipid Bilayers; Magnetic Resonance Spectroscopy; Phosphatidylcholines; Potassium; Pyrans; Sodium | 1990 |
Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Liposomes; Mice, Nude; Neoplasms, Experimental; Paclitaxel; Phosphatidylcholines; Polyethylene Glycols; Pyrans | 2021 |